Genflow Biosciences Cash Flow Statement

Financials in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Mar '21 Mar 31, 2021
Net Income	-1.8	-1.59	-1.86	-1.34	-1.08	-0.65
Depreciation & Amortization	0	0	0	0	-	-
Stock-Based Compensation	-0	-	-	0.07	0.02	-
Provision & Write-off of Bad Debts	-	-	-	-	0.05	-
Other Operating Activities	-	-	-	0.07	0	-
Change in Accounts Receivable	0.01	0.26	-0.13	-0.21	-0.05	-0.18
Change in Accounts Payable	0.07	0.24	0.33	0.03	0.24	0.39
Operating Cash Flow	-1.72	-1.08	-1.66	-1.37	-0.82	-0.44
Capital Expenditures	0	-	-0	-0	-	-
Cash Acquisitions	-	-	-	-	0.22	-
Investing Cash Flow	0	-	-0	-0	0.22	-
Issuance of Common Stock	0.86	0.66	-	3.76	0.85	1.96
Other Financing Activities	-	-	-	-0.26	-	-
Financing Cash Flow	0.86	0.66	-	3.5	0.85	1.96
Foreign Exchange Rate Adjustments	-0	0.02	-0.01	0	-	-
Miscellaneous Cash Flow Adjustments	-	-	-	-0	-0.01	-
Net Cash Flow	-0.86	-0.41	-1.67	2.13	0.24	1.53
Free Cash Flow	-1.72	-1.08	-1.66	-1.37	-0.82	-0.44
Free Cash Flow Per Share	-0.01	-0.00	-0.01	-0.01	-0.01	-0.55
Levered Free Cash Flow	-0.83	-0.49	-0.97	-0.94	-	-
Unlevered Free Cash Flow	-0.83	-0.49	-0.97	-0.94	-	-
Change in Working Capital	0.08	0.5	0.2	-0.18	0.19	0.21

Source: S&P Global Market Intelligence. Standard template. Financial Sources.